Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac.

Trial Profile

Immunogenicity After Two Doses of Meningococcal Outer Membrane Vesicle Vaccine MenBVac.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Apr 2013

At a glance

  • Drugs Meningococcal vaccine group B OMV (Primary)
  • Indications Meningococcal group B infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 14 Apr 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 May 2008 Status changed from recruiting to in prgoress, reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top